论文部分内容阅读
目的:分析尼莫地平对脑出血后缺血性脑损伤的临床效果。方法:收治脑出血后缺血性脑损伤患者100例,随机分为参考组和治疗组,各50例。参考组给予常规临床治疗,治疗组在参考组的基础上加用尼莫地平治疗。对比两组患者的疗效,且观察患者治疗前后的神经功能缺损情况、日常生活能力变化及不良反应。结果:治疗组的总有效率明显高于参考组(P<0.05);治疗组治疗后NIHSS评分明显低于治疗前、参考组同期,BI评分显著更高(P<0.05)。结论:尼莫地平治疗脑出血后缺血性脑损伤患者可有效提高疗效,且有助于改善其神经功能缺损及日常生活能力。
Objective: To analyze the clinical effect of nimodipine on ischemic brain injury after intracerebral hemorrhage. Methods: One hundred patients with intracerebral hemorrhage after ischemic brain injury were randomly divided into reference group and treatment group, 50 cases each. Reference group given conventional clinical treatment, the treatment group in the reference group plus nimodipine treatment. The curative effect of two groups of patients was compared, and the neurological deficits, changes of daily living ability and adverse reactions before and after treatment were observed. Results: The total effective rate of the treatment group was significantly higher than that of the reference group (P <0.05). The NIHSS score of the treatment group was significantly lower than that before treatment and the reference group (P <0.05). Conclusion: Nimodipine in patients with cerebral hemorrhage after cerebral hemorrhage can effectively improve the efficacy, and help to improve their neurological deficits and daily living ability.